Ali Salahpour

Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.

Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy.

Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer.

Biochemical characterization of beta2-adrenergic receptor dimers and oligomers.

Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting.

Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.

Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals.

Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2.

Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo.

Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization.

Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter.

Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor.

Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.

Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.

Noradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchrony.

The dopamine metabolite 3-methoxytyramine is a neuromodulator.

Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner.

Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor.

Visualizing receptor endocytosis and trafficking.

Food for thought: the physiological relevance of ghrelin and dopamine D2 receptor heterodimerization in the regulation of appetite.

The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment.

Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations.

Optimizing the Temporal Resolution of Fast-Scan Cyclic Voltammetry.

BRET biosensors to study GPCR biology, pharmacology, and signal transduction.

BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling.

Measurement of G protein-coupled receptor surface expression.

A novel assay for measurement of membrane-protein surface expression using a β-lactamase.

Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression.

D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice.

N-terminal tagging of the dopamine transporter impairs protein expression and trafficking in vivo.

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo.